ALNY logo

Alnylam Pharmaceuticals, Inc. (ALNY)

Profile

Full Name

Alnylam Pharmaceuticals, Inc.

Ticker

NASDAQ: ALNY

Exchange

NASDAQ

Country

United States

IPO

June 1, 2004

Indexes

Not included

Employees

2230

Key Details

Price

$314.94(-2.39%)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.25B(+22.97% YoY)

Annual EPS

-$2.18(+38.07% YoY)

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
See Full Chart & Historical Data

Analyst ratings

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Jun 30, 25 Wells Fargo
Equal-Weight
Jun 26, 25 Needham
Buy
Jun 24, 25 BMO Capital
Outperform
Jun 12, 25 JP Morgan
Overweight
May 2, 25 UBS
Buy
May 2, 25 Chardan Capital
Buy
Apr 11, 25 Morgan Stanley
Equal-Weight
Apr 9, 25 Needham
Buy
Apr 2, 25 HC Wainwright & Co.
Buy
Mar 31, 25 Stifel
Buy

Institutional Ownership

  • What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?
  • Does Alnylam Pharmaceuticals, Inc. pay dividends?
  • What sector is Alnylam Pharmaceuticals, Inc. in?
  • What industry is Alnylam Pharmaceuticals, Inc. in?
  • What country is Alnylam Pharmaceuticals, Inc. based in?
  • When did Alnylam Pharmaceuticals, Inc. go public?
  • Is Alnylam Pharmaceuticals, Inc. in the S&P 500?
  • Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?
  • Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?
  • When was Alnylam Pharmaceuticals, Inc.'s last earnings report?
  • When does Alnylam Pharmaceuticals, Inc. report earnings?

What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?

The ticker symbol for Alnylam Pharmaceuticals, Inc. is NASDAQ:ALNY

Does Alnylam Pharmaceuticals, Inc. pay dividends?

No, Alnylam Pharmaceuticals, Inc. does not pay dividends

What sector is Alnylam Pharmaceuticals, Inc. in?

Alnylam Pharmaceuticals, Inc. is in the Healthcare sector

What industry is Alnylam Pharmaceuticals, Inc. in?

Alnylam Pharmaceuticals, Inc. is in the Biotechnology industry

What country is Alnylam Pharmaceuticals, Inc. based in?

Alnylam Pharmaceuticals, Inc. is headquartered in United States

When did Alnylam Pharmaceuticals, Inc. go public?

Alnylam Pharmaceuticals, Inc.'s initial public offering (IPO) was on June 1, 2004

Is Alnylam Pharmaceuticals, Inc. in the S&P 500?

No, Alnylam Pharmaceuticals, Inc. is not included in the S&P 500 index

Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?

No, Alnylam Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?

No, Alnylam Pharmaceuticals, Inc. is not included in the Dow Jones index

When was Alnylam Pharmaceuticals, Inc.'s last earnings report?

Alnylam Pharmaceuticals, Inc.'s most recent earnings report was on May 1, 2025

When does Alnylam Pharmaceuticals, Inc. report earnings?

The next expected earnings date for Alnylam Pharmaceuticals, Inc. is August 1, 2025
On this page